[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$flJ2dX3oEoonss3kZgQld6uKV3w9MPpoZmy0FJMhV8fQ":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":34,"rows":41},"Kuopio University Hospital",[4],133,false,22,6,101541,0,103,[14,17,19,22,24,26,29,31],{"name":15,"count":16},"Atrial Fibrillation",8,{"name":18,"count":9},"Pain",{"name":20,"count":21},"Depression",4,{"name":23,"count":21},"Labor Pain",{"name":25,"count":21},"Pain, Postoperative",{"name":27,"count":28},"Coronary Artery Disease",3,{"name":30,"count":28},"Constipation",{"name":32,"count":28},"Carpal Tunnel Syndrome",[],[35,36,37,38,39,40],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[42,79,105,130,154,172,196,224,242,260,285,309,334,359,377,402,420,444,467,493,511,537,555,581,629,660,681,699,723,748,773,798,820,846,864,887,914],{"intervention":43,"totalTrials":44,"cells":45},"oxycodone-naloxone",2,{"EARLY_PHASE1":46,"PHASE1":48,"PHASE2":50,"PHASE3":52,"PHASE4":54,"NA":77},{"trials":47,"activeCount":11},[],{"trials":49,"activeCount":11},[],{"trials":51,"activeCount":11},[],{"trials":53,"activeCount":11},[],{"trials":55,"activeCount":11},[56,67],{"nctId":57,"briefTitle":58,"status":59,"phases":60,"primaryCompletion":61,"completion":61,"start":62,"enrollment":63,"conditions":64,"interventions":65},"NCT02573922","Opioid Induced Bowel Dysfunction in Patients Undergoing Spinal Surgery","COMPLETED",[39],"2014-12","2012-05",180,[30],[43,66],"Oxycodone",{"nctId":68,"briefTitle":69,"status":70,"phases":71,"primaryCompletion":72,"completion":72,"start":73,"enrollment":74,"conditions":75,"interventions":76},"NCT02571881","Opioid Induced Bowel Dysfunction in Patients Undergoing Cesarean Section","UNKNOWN",[39],"2023-12","2012-10",57,[30,25],[66,43],{"trials":78,"activeCount":11},[],{"intervention":80,"totalTrials":81,"cells":82},"Buprenorphine",1,{"EARLY_PHASE1":83,"PHASE1":85,"PHASE2":87,"PHASE3":89,"PHASE4":91,"NA":103},{"trials":84,"activeCount":11},[],{"trials":86,"activeCount":11},[],{"trials":88,"activeCount":11},[],{"trials":90,"activeCount":11},[],{"trials":92,"activeCount":11},[93],{"nctId":94,"briefTitle":95,"status":59,"phases":96,"primaryCompletion":97,"completion":97,"start":98,"enrollment":99,"conditions":100,"interventions":102},"NCT02575664","Effects of Low Dose Buprenorphine on Recovery After Hip or Knee Arthroplasty",[39],"2015-10","2012-08",160,[18,101],"Osteoarthritis",[80],{"trials":104,"activeCount":11},[],{"intervention":106,"totalTrials":81,"cells":107},"levosimendan",{"EARLY_PHASE1":108,"PHASE1":110,"PHASE2":112,"PHASE3":114,"PHASE4":116,"NA":128},{"trials":109,"activeCount":11},[],{"trials":111,"activeCount":11},[],{"trials":113,"activeCount":11},[],{"trials":115,"activeCount":11},[],{"trials":117,"activeCount":11},[118],{"nctId":119,"briefTitle":120,"status":59,"phases":121,"primaryCompletion":122,"completion":122,"start":123,"enrollment":124,"conditions":125,"interventions":127},"NCT00154115","Levosimendan in High Risk Heart Valve Surgery",[39],"2008-12","2005-03",200,[126],"Heart Failure",[106],{"trials":129,"activeCount":11},[],{"intervention":131,"totalTrials":81,"cells":132},"Dexketoprofen",{"EARLY_PHASE1":133,"PHASE1":135,"PHASE2":137,"PHASE3":139,"PHASE4":141,"NA":152},{"trials":134,"activeCount":11},[],{"trials":136,"activeCount":11},[],{"trials":138,"activeCount":11},[],{"trials":140,"activeCount":11},[],{"trials":142,"activeCount":11},[143],{"nctId":144,"briefTitle":145,"status":59,"phases":146,"primaryCompletion":61,"completion":61,"start":147,"enrollment":148,"conditions":149,"interventions":150},"NCT02568735","Dexketoprofen and Etoricoxib in Patients Undergoing Hip Arthroplasty",[39],"2013-01",24,[25],[131,151],"Etoricoxib",{"trials":153,"activeCount":11},[],{"intervention":151,"totalTrials":81,"cells":155},{"EARLY_PHASE1":156,"PHASE1":158,"PHASE2":160,"PHASE3":162,"PHASE4":164,"NA":170},{"trials":157,"activeCount":11},[],{"trials":159,"activeCount":11},[],{"trials":161,"activeCount":11},[],{"trials":163,"activeCount":11},[],{"trials":165,"activeCount":11},[166],{"nctId":144,"briefTitle":145,"status":59,"phases":167,"primaryCompletion":61,"completion":61,"start":147,"enrollment":148,"conditions":168,"interventions":169},[39],[25],[131,151],{"trials":171,"activeCount":11},[],{"intervention":173,"totalTrials":81,"cells":174},"intranasal fentanyl 50 microg dose up to 250 microg",{"EARLY_PHASE1":175,"PHASE1":177,"PHASE2":179,"PHASE3":181,"PHASE4":183,"NA":194},{"trials":176,"activeCount":11},[],{"trials":178,"activeCount":11},[],{"trials":180,"activeCount":11},[],{"trials":182,"activeCount":11},[],{"trials":184,"activeCount":11},[185],{"nctId":186,"briefTitle":187,"status":59,"phases":188,"primaryCompletion":189,"completion":189,"start":190,"enrollment":191,"conditions":192,"interventions":193},"NCT02571179","Intranasal Fentanyl in Treatment of Labour Pain",[39],"2021-03","2011-01",20,[23],[173],{"trials":195,"activeCount":11},[],{"intervention":197,"totalTrials":81,"cells":198},"Levobupivacaine continuous",{"EARLY_PHASE1":199,"PHASE1":201,"PHASE2":203,"PHASE3":205,"PHASE4":207,"NA":222},{"trials":200,"activeCount":11},[],{"trials":202,"activeCount":11},[],{"trials":204,"activeCount":11},[],{"trials":206,"activeCount":11},[],{"trials":208,"activeCount":11},[209],{"nctId":210,"briefTitle":211,"status":59,"phases":212,"primaryCompletion":213,"completion":214,"start":215,"enrollment":74,"conditions":216,"interventions":219},"NCT02869841","Efficacy of Rectal Sheath Analgesia After Midline Laparotomy",[39],"2018-07","2022-12-31","2012-01",[217,218],"Surgery","Pain Postoperative",[197,220,221],"levobupivacaine bolus dosing","single bolus of levobupivacaine",{"trials":223,"activeCount":11},[],{"intervention":220,"totalTrials":81,"cells":225},{"EARLY_PHASE1":226,"PHASE1":228,"PHASE2":230,"PHASE3":232,"PHASE4":234,"NA":240},{"trials":227,"activeCount":11},[],{"trials":229,"activeCount":11},[],{"trials":231,"activeCount":11},[],{"trials":233,"activeCount":11},[],{"trials":235,"activeCount":11},[236],{"nctId":210,"briefTitle":211,"status":59,"phases":237,"primaryCompletion":213,"completion":214,"start":215,"enrollment":74,"conditions":238,"interventions":239},[39],[217,218],[197,220,221],{"trials":241,"activeCount":11},[],{"intervention":221,"totalTrials":81,"cells":243},{"EARLY_PHASE1":244,"PHASE1":246,"PHASE2":248,"PHASE3":250,"PHASE4":252,"NA":258},{"trials":245,"activeCount":11},[],{"trials":247,"activeCount":11},[],{"trials":249,"activeCount":11},[],{"trials":251,"activeCount":11},[],{"trials":253,"activeCount":11},[254],{"nctId":210,"briefTitle":211,"status":59,"phases":255,"primaryCompletion":213,"completion":214,"start":215,"enrollment":74,"conditions":256,"interventions":257},[39],[217,218],[197,220,221],{"trials":259,"activeCount":11},[],{"intervention":261,"totalTrials":81,"cells":262},"Ropivacaine",{"EARLY_PHASE1":263,"PHASE1":265,"PHASE2":267,"PHASE3":269,"PHASE4":271,"NA":283},{"trials":264,"activeCount":11},[],{"trials":266,"activeCount":11},[],{"trials":268,"activeCount":11},[],{"trials":270,"activeCount":11},[],{"trials":272,"activeCount":11},[273],{"nctId":274,"briefTitle":275,"status":59,"phases":276,"primaryCompletion":277,"completion":277,"start":278,"enrollment":279,"conditions":280,"interventions":282},"NCT02449486","Ropivacaine After Sternotomy",[39],"2017-12","2014-01",90,[281],"Postoperative Pain",[261],{"trials":284,"activeCount":11},[],{"intervention":286,"totalTrials":81,"cells":287},"remifentanil",{"EARLY_PHASE1":288,"PHASE1":290,"PHASE2":292,"PHASE3":294,"PHASE4":296,"NA":307},{"trials":289,"activeCount":11},[],{"trials":291,"activeCount":11},[],{"trials":293,"activeCount":11},[],{"trials":295,"activeCount":11},[],{"trials":297,"activeCount":11},[298],{"nctId":299,"briefTitle":300,"status":59,"phases":301,"primaryCompletion":302,"completion":303,"start":304,"enrollment":279,"conditions":305,"interventions":306},"NCT00757198","Requirement of Analgesics After Two Remifentanil Dosing Regimen in Cardiac Surgery.",[39],"2011-11","2011-12","2008-09",[18],[286,286],{"trials":308,"activeCount":11},[],{"intervention":310,"totalTrials":81,"cells":311},"metoprolol, amiodarone",{"EARLY_PHASE1":312,"PHASE1":314,"PHASE2":316,"PHASE3":318,"PHASE4":320,"NA":332},{"trials":313,"activeCount":11},[],{"trials":315,"activeCount":11},[],{"trials":317,"activeCount":11},[],{"trials":319,"activeCount":11},[],{"trials":321,"activeCount":11},[322],{"nctId":323,"briefTitle":324,"status":59,"phases":325,"primaryCompletion":326,"completion":326,"start":327,"enrollment":328,"conditions":329,"interventions":331},"NCT00784316","Intravenous Metoprolol Versus Intravenous Amiodarone in the Prevention of Atrial Fibrillation After Cardiac Surgery",[39],"2009-07","2007-08",316,[15,330],"Cardiac Surgery",[310],{"trials":333,"activeCount":11},[],{"intervention":335,"totalTrials":81,"cells":336},"Oxycodone intravenously",{"EARLY_PHASE1":337,"PHASE1":339,"PHASE2":341,"PHASE3":343,"PHASE4":345,"NA":357},{"trials":338,"activeCount":11},[],{"trials":340,"activeCount":11},[],{"trials":342,"activeCount":11},[],{"trials":344,"activeCount":11},[],{"trials":346,"activeCount":11},[347],{"nctId":348,"briefTitle":349,"status":70,"phases":350,"primaryCompletion":351,"completion":351,"start":352,"enrollment":353,"conditions":354,"interventions":355},"NCT02573909","The Safety and Efficacy of Epidural Oxycodone",[39],"2023-12-31","2015-01-01",100,[25],[335,356],"Oxycodone epidurally",{"trials":358,"activeCount":11},[],{"intervention":356,"totalTrials":81,"cells":360},{"EARLY_PHASE1":361,"PHASE1":363,"PHASE2":365,"PHASE3":367,"PHASE4":369,"NA":375},{"trials":362,"activeCount":11},[],{"trials":364,"activeCount":11},[],{"trials":366,"activeCount":11},[],{"trials":368,"activeCount":11},[],{"trials":370,"activeCount":11},[371],{"nctId":348,"briefTitle":349,"status":70,"phases":372,"primaryCompletion":351,"completion":351,"start":352,"enrollment":353,"conditions":373,"interventions":374},[39],[25],[335,356],{"trials":376,"activeCount":11},[],{"intervention":378,"totalTrials":81,"cells":379},"Metoprolol",{"EARLY_PHASE1":380,"PHASE1":382,"PHASE2":384,"PHASE3":386,"PHASE4":398,"NA":400},{"trials":381,"activeCount":11},[],{"trials":383,"activeCount":11},[],{"trials":385,"activeCount":11},[],{"trials":387,"activeCount":11},[388],{"nctId":389,"briefTitle":390,"status":391,"phases":392,"primaryCompletion":393,"completion":393,"start":393,"enrollment":11,"conditions":394,"interventions":396},"NCT02269696","The Effect of Metoprolol on Anaesthesia, the Need for Analgesics, and Pain in Breast Cancer Patients","WITHDRAWN",[38],"2018-03-21",[395],"Breast Cancer",[378,397],"Normal saline",{"trials":399,"activeCount":11},[],{"trials":401,"activeCount":11},[],{"intervention":397,"totalTrials":81,"cells":403},{"EARLY_PHASE1":404,"PHASE1":406,"PHASE2":408,"PHASE3":410,"PHASE4":416,"NA":418},{"trials":405,"activeCount":11},[],{"trials":407,"activeCount":11},[],{"trials":409,"activeCount":11},[],{"trials":411,"activeCount":11},[412],{"nctId":389,"briefTitle":390,"status":391,"phases":413,"primaryCompletion":393,"completion":393,"start":393,"enrollment":11,"conditions":414,"interventions":415},[38],[395],[378,397],{"trials":417,"activeCount":11},[],{"trials":419,"activeCount":11},[],{"intervention":421,"totalTrials":81,"cells":422},"Adalimumab injections for acute disc prolapse patients",{"EARLY_PHASE1":423,"PHASE1":425,"PHASE2":427,"PHASE3":429,"PHASE4":440,"NA":442},{"trials":424,"activeCount":11},[],{"trials":426,"activeCount":11},[],{"trials":428,"activeCount":11},[],{"trials":430,"activeCount":11},[431],{"nctId":432,"briefTitle":433,"status":70,"phases":434,"primaryCompletion":435,"completion":435,"start":436,"enrollment":279,"conditions":437,"interventions":439},"NCT01510548","ADALISKIAS: Adalimumab for Acute Disc Prolapse",[38],"2014-07","2007-03",[438,18],"Disc Prolapse",[421],{"trials":441,"activeCount":11},[],{"trials":443,"activeCount":11},[],{"intervention":445,"totalTrials":81,"cells":446},"Placebos",{"EARLY_PHASE1":447,"PHASE1":449,"PHASE2":451,"PHASE3":453,"PHASE4":463,"NA":465},{"trials":448,"activeCount":11},[],{"trials":450,"activeCount":11},[],{"trials":452,"activeCount":11},[],{"trials":454,"activeCount":11},[455],{"nctId":456,"briefTitle":457,"status":391,"phases":458,"primaryCompletion":214,"completion":214,"start":459,"enrollment":11,"conditions":460,"interventions":461},"NCT03682393","Post-operative Corticosteroid Treatment After Mitral Valve Surgery",[37,38],"2020-01-01",[15],[462,445],"Hydrocortisone",{"trials":464,"activeCount":11},[],{"trials":466,"activeCount":11},[],{"intervention":468,"totalTrials":81,"cells":469},"AdvVEGF-D",{"EARLY_PHASE1":470,"PHASE1":472,"PHASE2":474,"PHASE3":487,"PHASE4":489,"NA":491},{"trials":471,"activeCount":11},[],{"trials":473,"activeCount":11},[],{"trials":475,"activeCount":11},[476],{"nctId":477,"briefTitle":478,"status":59,"phases":479,"primaryCompletion":351,"completion":351,"start":480,"enrollment":481,"conditions":482,"interventions":485},"NCT03039751","Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris",[37],"2019-10-19",63,[483,484,27],"Refractory Angina Pectoris","Gene Transfer",[468,486],"Control Rx",{"trials":488,"activeCount":11},[],{"trials":490,"activeCount":11},[],{"trials":492,"activeCount":11},[],{"intervention":486,"totalTrials":81,"cells":494},{"EARLY_PHASE1":495,"PHASE1":497,"PHASE2":499,"PHASE3":505,"PHASE4":507,"NA":509},{"trials":496,"activeCount":11},[],{"trials":498,"activeCount":11},[],{"trials":500,"activeCount":11},[501],{"nctId":477,"briefTitle":478,"status":59,"phases":502,"primaryCompletion":351,"completion":351,"start":480,"enrollment":481,"conditions":503,"interventions":504},[37],[483,484,27],[468,486],{"trials":506,"activeCount":11},[],{"trials":508,"activeCount":11},[],{"trials":510,"activeCount":11},[],{"intervention":512,"totalTrials":81,"cells":513},"Cyclophosphamide",{"EARLY_PHASE1":514,"PHASE1":516,"PHASE2":518,"PHASE3":531,"PHASE4":533,"NA":535},{"trials":515,"activeCount":11},[],{"trials":517,"activeCount":11},[],{"trials":519,"activeCount":11},[520],{"nctId":521,"briefTitle":522,"status":59,"phases":523,"primaryCompletion":524,"completion":525,"start":147,"enrollment":526,"conditions":527,"interventions":529},"NCT01790737","First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02",[37],"2018-10-10","2019-02-26",80,[528],"Multiple Myeloma",[512,530],"Filgrastim",{"trials":532,"activeCount":11},[],{"trials":534,"activeCount":11},[],{"trials":536,"activeCount":11},[],{"intervention":530,"totalTrials":81,"cells":538},{"EARLY_PHASE1":539,"PHASE1":541,"PHASE2":543,"PHASE3":549,"PHASE4":551,"NA":553},{"trials":540,"activeCount":11},[],{"trials":542,"activeCount":11},[],{"trials":544,"activeCount":11},[545],{"nctId":521,"briefTitle":522,"status":59,"phases":546,"primaryCompletion":524,"completion":525,"start":147,"enrollment":526,"conditions":547,"interventions":548},[37],[528],[512,530],{"trials":550,"activeCount":11},[],{"trials":552,"activeCount":11},[],{"trials":554,"activeCount":11},[],{"intervention":556,"totalTrials":81,"cells":557},"VEGF-D gene transfer",{"EARLY_PHASE1":558,"PHASE1":560,"PHASE2":573,"PHASE3":575,"PHASE4":577,"NA":579},{"trials":559,"activeCount":11},[],{"trials":561,"activeCount":11},[562],{"nctId":563,"briefTitle":564,"status":59,"phases":565,"primaryCompletion":566,"completion":566,"start":567,"enrollment":568,"conditions":569,"interventions":572},"NCT01002430","EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease",[36],"2015-06-15","2010-01-10",30,[570,571],"Angina Pectoris","Myocardial Infarction",[556],{"trials":574,"activeCount":11},[],{"trials":576,"activeCount":11},[],{"trials":578,"activeCount":11},[],{"trials":580,"activeCount":11},[],{"intervention":66,"totalTrials":582,"cells":583},5,{"EARLY_PHASE1":584,"PHASE1":586,"PHASE2":588,"PHASE3":590,"PHASE4":592,"NA":609},{"trials":585,"activeCount":11},[],{"trials":587,"activeCount":11},[],{"trials":589,"activeCount":11},[],{"trials":591,"activeCount":11},[],{"trials":593,"activeCount":11},[594,598,605],{"nctId":57,"briefTitle":58,"status":59,"phases":595,"primaryCompletion":61,"completion":61,"start":62,"enrollment":63,"conditions":596,"interventions":597},[39],[30],[43,66],{"nctId":599,"briefTitle":600,"status":70,"phases":601,"primaryCompletion":351,"completion":351,"start":602,"enrollment":8,"conditions":603,"interventions":604},"NCT02573831","The Effect of Oxycodone to the Placental Circulation at Early Labour",[39],"2015-02-01",[23],[66],{"nctId":68,"briefTitle":69,"status":70,"phases":606,"primaryCompletion":72,"completion":72,"start":73,"enrollment":74,"conditions":607,"interventions":608},[39],[30,25],[66,43],{"trials":610,"activeCount":11},[611,620],{"nctId":612,"briefTitle":613,"status":59,"phases":614,"primaryCompletion":615,"completion":615,"start":616,"enrollment":617,"conditions":618,"interventions":619},"NCT02564003","Oxycodone Pharmacokinetics in Preterm Infants",[],"2013-08","2012-06",79,[18],[66],{"nctId":621,"briefTitle":622,"status":59,"phases":623,"primaryCompletion":624,"completion":624,"start":625,"enrollment":626,"conditions":627,"interventions":628},"NCT01016821","Oxycodone for Labor Pain - Pharmacokinetics (PK), Safety and Efficacy",[40],"2010-12","2009-11",15,[23],[66],{"intervention":630,"totalTrials":44,"cells":631},"hydrocortisone",{"EARLY_PHASE1":632,"PHASE1":634,"PHASE2":636,"PHASE3":638,"PHASE4":644,"NA":646},{"trials":633,"activeCount":11},[],{"trials":635,"activeCount":11},[],{"trials":637,"activeCount":11},[],{"trials":639,"activeCount":11},[640],{"nctId":456,"briefTitle":457,"status":391,"phases":641,"primaryCompletion":214,"completion":214,"start":459,"enrollment":11,"conditions":642,"interventions":643},[37,38],[15],[462,445],{"trials":645,"activeCount":11},[],{"trials":647,"activeCount":11},[648],{"nctId":649,"briefTitle":650,"status":651,"phases":652,"primaryCompletion":653,"completion":303,"start":654,"enrollment":655,"conditions":656,"interventions":658},"NCT00675272","Organ Donation and Hydrocortisone Treatment","TERMINATED",[40],"2011-08","2008-05",38,[657],"Brain Death",[630,659],"sodium chloride",{"intervention":661,"totalTrials":81,"cells":662},"intravenous hydrocortisone",{"EARLY_PHASE1":663,"PHASE1":665,"PHASE2":667,"PHASE3":669,"PHASE4":671,"NA":673},{"trials":664,"activeCount":11},[],{"trials":666,"activeCount":11},[],{"trials":668,"activeCount":11},[],{"trials":670,"activeCount":11},[],{"trials":672,"activeCount":11},[],{"trials":674,"activeCount":11},[675],{"nctId":676,"briefTitle":677,"status":651,"phases":678,"primaryCompletion":73,"completion":73,"start":73,"enrollment":81,"conditions":679,"interventions":680},"NCT00442494","Corticosteroids for the Prevention of Atrial Fibrillation After Cardiac Surgery",[40],[15],[661],{"intervention":659,"totalTrials":81,"cells":682},{"EARLY_PHASE1":683,"PHASE1":685,"PHASE2":687,"PHASE3":689,"PHASE4":691,"NA":693},{"trials":684,"activeCount":11},[],{"trials":686,"activeCount":11},[],{"trials":688,"activeCount":11},[],{"trials":690,"activeCount":11},[],{"trials":692,"activeCount":11},[],{"trials":694,"activeCount":11},[695],{"nctId":649,"briefTitle":650,"status":651,"phases":696,"primaryCompletion":653,"completion":303,"start":654,"enrollment":655,"conditions":697,"interventions":698},[40],[657],[630,659],{"intervention":700,"totalTrials":81,"cells":701},"Methadone, naloxone",{"EARLY_PHASE1":702,"PHASE1":704,"PHASE2":706,"PHASE3":708,"PHASE4":710,"NA":712},{"trials":703,"activeCount":11},[],{"trials":705,"activeCount":11},[],{"trials":707,"activeCount":11},[],{"trials":709,"activeCount":11},[],{"trials":711,"activeCount":11},[],{"trials":713,"activeCount":11},[714],{"nctId":715,"briefTitle":716,"status":391,"phases":717,"primaryCompletion":718,"completion":718,"start":719,"enrollment":11,"conditions":720,"interventions":722},"NCT01160432","Naloxone Methadone Combination (NAMEKO)",[40],"2013-07","2013-05",[721],"Opiate Dependence",[700],{"intervention":724,"totalTrials":81,"cells":725},"blood concentration of metoprolol",{"EARLY_PHASE1":726,"PHASE1":728,"PHASE2":730,"PHASE3":732,"PHASE4":734,"NA":736},{"trials":727,"activeCount":11},[],{"trials":729,"activeCount":11},[],{"trials":731,"activeCount":11},[],{"trials":733,"activeCount":11},[],{"trials":735,"activeCount":11},[],{"trials":737,"activeCount":11},[738],{"nctId":739,"briefTitle":740,"status":70,"phases":741,"primaryCompletion":742,"completion":742,"start":743,"enrollment":744,"conditions":745,"interventions":747},"NCT01728272","Influence of CPB and Mini CPB to the Absorption of the Metoprolol",[40],"2015-12","2012-11",45,[746],"Drug Absorption",[724],{"intervention":749,"totalTrials":81,"cells":750},"budesonide",{"EARLY_PHASE1":751,"PHASE1":753,"PHASE2":755,"PHASE3":757,"PHASE4":759,"NA":761},{"trials":752,"activeCount":11},[],{"trials":754,"activeCount":11},[],{"trials":756,"activeCount":11},[],{"trials":758,"activeCount":11},[],{"trials":760,"activeCount":11},[],{"trials":762,"activeCount":11},[763],{"nctId":764,"briefTitle":765,"status":59,"phases":766,"primaryCompletion":767,"completion":767,"start":768,"enrollment":769,"conditions":770,"interventions":772},"NCT00859274","Saline Challenge in Monitoring Asthma Control",[40],"2013-10","2009-03",40,[771],"Asthma",[749],{"intervention":774,"totalTrials":81,"cells":775},"Oxygen gas",{"EARLY_PHASE1":776,"PHASE1":778,"PHASE2":780,"PHASE3":782,"PHASE4":784,"NA":786},{"trials":777,"activeCount":11},[],{"trials":779,"activeCount":11},[],{"trials":781,"activeCount":11},[],{"trials":783,"activeCount":11},[],{"trials":785,"activeCount":11},[],{"trials":787,"activeCount":11},[788],{"nctId":789,"briefTitle":790,"status":70,"phases":791,"primaryCompletion":792,"completion":351,"start":793,"enrollment":794,"conditions":795,"interventions":797},"NCT04554225","Pulmonary Disease Requiring Ambulatory Oxygen Therapy -Resilience and Quality of Life",[],"2022-07-29","2017-11-01",43,[796],"Pulmonary Disease",[774],{"intervention":799,"totalTrials":81,"cells":800},"rivastigmine",{"EARLY_PHASE1":801,"PHASE1":803,"PHASE2":805,"PHASE3":807,"PHASE4":809,"NA":811},{"trials":802,"activeCount":11},[],{"trials":804,"activeCount":11},[],{"trials":806,"activeCount":11},[],{"trials":808,"activeCount":11},[],{"trials":810,"activeCount":11},[],{"trials":812,"activeCount":11},[813],{"nctId":814,"briefTitle":815,"status":59,"phases":816,"primaryCompletion":122,"completion":122,"start":436,"enrollment":191,"conditions":817,"interventions":819},"NCT00627848","Rivastigmine in Mild Alzheimer's Disease, FMRI Study",[40],[818],"Alzheimer' Disease",[799],{"intervention":821,"totalTrials":81,"cells":822},"rituximab",{"EARLY_PHASE1":823,"PHASE1":825,"PHASE2":827,"PHASE3":829,"PHASE4":831,"NA":833},{"trials":824,"activeCount":11},[],{"trials":826,"activeCount":11},[],{"trials":828,"activeCount":11},[],{"trials":830,"activeCount":11},[],{"trials":832,"activeCount":11},[],{"trials":834,"activeCount":11},[835],{"nctId":836,"briefTitle":837,"status":59,"phases":838,"primaryCompletion":839,"completion":839,"start":840,"enrollment":841,"conditions":842,"interventions":844},"NCT00854321","Patients With Rheumatoid Arthritis (RA) Treated With Rituximab in Kuopio University Hospital",[],"2008-07","2004-11",49,[843],"Rheumatoid Arthritis",[821,845],"rituximab, observational study amon patients with active RA",{"intervention":845,"totalTrials":81,"cells":847},{"EARLY_PHASE1":848,"PHASE1":850,"PHASE2":852,"PHASE3":854,"PHASE4":856,"NA":858},{"trials":849,"activeCount":11},[],{"trials":851,"activeCount":11},[],{"trials":853,"activeCount":11},[],{"trials":855,"activeCount":11},[],{"trials":857,"activeCount":11},[],{"trials":859,"activeCount":11},[860],{"nctId":836,"briefTitle":837,"status":59,"phases":861,"primaryCompletion":839,"completion":839,"start":840,"enrollment":841,"conditions":862,"interventions":863},[],[843],[821,845],{"intervention":865,"totalTrials":81,"cells":866},"Asthma medication reduction",{"EARLY_PHASE1":867,"PHASE1":869,"PHASE2":871,"PHASE3":873,"PHASE4":875,"NA":877},{"trials":868,"activeCount":11},[],{"trials":870,"activeCount":11},[],{"trials":872,"activeCount":11},[],{"trials":874,"activeCount":11},[],{"trials":876,"activeCount":11},[],{"trials":878,"activeCount":11},[879],{"nctId":880,"briefTitle":881,"status":59,"phases":882,"primaryCompletion":883,"completion":883,"start":73,"enrollment":884,"conditions":885,"interventions":886},"NCT01961154","Stepping Down of Asthma Medication in Controlled Asthma",[40],"2015-07",56,[771],[865],{"intervention":888,"totalTrials":81,"cells":889},"Klodronate and Kliogest",{"EARLY_PHASE1":890,"PHASE1":892,"PHASE2":894,"PHASE3":896,"PHASE4":898,"NA":900},{"trials":891,"activeCount":11},[],{"trials":893,"activeCount":11},[],{"trials":895,"activeCount":11},[],{"trials":897,"activeCount":11},[],{"trials":899,"activeCount":11},[],{"trials":901,"activeCount":11},[902],{"nctId":903,"briefTitle":904,"status":59,"phases":905,"primaryCompletion":906,"completion":907,"start":908,"enrollment":909,"conditions":910,"interventions":912},"NCT00877097","Effects of Continuous Combined Hormone Replacement Therapy and Clodronate on Bone Mineral Density (BMD) in Osteoporotic Women",[40],"2002-12","2009-02","1996-07",167,[911],"Osteoporosis",[888,913],"Bonefos",{"intervention":913,"totalTrials":81,"cells":915},{"EARLY_PHASE1":916,"PHASE1":918,"PHASE2":920,"PHASE3":922,"PHASE4":924,"NA":926},{"trials":917,"activeCount":11},[],{"trials":919,"activeCount":11},[],{"trials":921,"activeCount":11},[],{"trials":923,"activeCount":11},[],{"trials":925,"activeCount":11},[],{"trials":927,"activeCount":11},[928],{"nctId":903,"briefTitle":904,"status":59,"phases":929,"primaryCompletion":906,"completion":907,"start":908,"enrollment":909,"conditions":930,"interventions":931},[40],[911],[888,913]]